Value in Prescribing biological disease-modifying antirheumatic drugs (bDMARDs) Program


Targeted Therapies Alliance

The Society of Hospital Pharmacists of Australia (SHPA) has joined NPS MedicineWise and seven other organisations representing pharmacists, specialists, consumers and research experts to form the Targeted Therapies Alliance (the Alliance). The Alliance provides stewardship and direction about the safe and wise use of biological disease-modifying antirheumatic drugs (bDMARDs) and other specialised medicines.

Resources developed and under development include:

Rheumatology interventions

The Alliance has developed information and resources for health professionals and consumers, including practical tools for people with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS).

Resources for pharmacists

For more information, visit the Rheumatology conditions for health professionals page on the NPS MedicineWise website.

Patient resources

  • Video: Living with methotrexate
    In this video, consumer Suzanne talks about her treatment journey and the impact methotrexate has had on her rheumatoid arthritis.
  • Methotrexate action plan (PDF)
    This action plan can help patients discuss methotrexate with their rheumatologist and plan the best way to take their medicine.

For more information, visit the Rheumatology conditions for consumers page on the NPS MedicineWise website.

Inflammatory bowel disease

The Alliance has worked closely with Crohn’s & Colitis Australia and the Gastroenterological Society of Australia to develop the following new resources, created with input from consumers with IBD and gastroenterologists:

  • patient action plan to help people learn about the benefits and risks of thiopurines for Crohn’s disease and ulcerative colitis with their gastroenterologist
  • decision aid to help people make decisions about how to use the medicines  for ulcerative colitis and their benefits in collaboration with a gastroenterologist.
  • patient action plan to help people discuss low-dose methotrexate for Crohn’s disease with their gastroenterologist.

Other resources to help people manage their treatments for inflammatory bowel disease include the NPS MedicineWise app, to keep track of medicines and remind people when medicine doses and appointments are due, and the Medicines list, a useful way to keep medicine information together.

Dermatology and gastroenterology interventions

The Alliance is currently working closely with dermatology and gastroenterology professional and consumer organisations to design and develop resources and materials for these conditions, and these will be available from mid-2021.